PCI Biotech Holding ASA (0JGL.L)

LSE • Currency in NOK

kr 0.38

-kr 0.01

-2.56%

Last Update: 28 Aug 2025, 14:01

kr 14.22M

Market Cap

0.00

P/E Ratio (TTM)

—

Forward Dividend Yield

kr 0.38 - kr 0.42

52 Week Range

0JGL.L Stock Price Chart

Explore PCI Biotech Holding ASA interactive price chart. Choose custom timeframes to analyze 0JGL.L price movements and trends.

0JGL.L Company Profile

Discover essential business fundamentals and corporate details for PCI Biotech Holding ASA (0JGL.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

18 Jun 2008

Employees

5.00

Website

https://www.pcibiotech.com

CEO

Ronny Skuggedal

Description

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.

0JGL.L Financial Timeline

Browse a chronological timeline of PCI Biotech Holding ASA corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Aug 2026

Earnings released on 23 May 2025

Earnings released on 27 Feb 2025

Earnings released on 28 Aug 2024

EPS came in at -kr 0.10 , while revenue for the quarter reached kr 1.71M .

Earnings released on 24 May 2024

EPS came in at -kr 0.10 , while revenue for the quarter reached kr 1.71M .

Earnings released on 14 Feb 2024

EPS came in at -kr 0.11 , while revenue for the quarter reached kr 1.29M .

Earnings released on 31 Dec 2023

EPS came in at -kr 0.11 , while revenue for the quarter reached kr 1.29M .

Earnings released on 30 Jun 2023

EPS came in at -kr 0.15 , while revenue for the quarter reached kr 185.00K .

Earnings released on 31 Mar 2023

EPS came in at -kr 0.16 , while revenue for the quarter reached kr 232.00K .

Earnings released on 31 Dec 2022

EPS came in at -kr 0.18 , while revenue for the quarter reached kr 1.19M .

Earnings released on 30 Sept 2022

EPS came in at -kr 0.29 , while revenue for the quarter reached kr 1.19M .

Earnings released on 30 Jun 2022

EPS came in at -kr 0.39 , while revenue for the quarter reached kr 1.19M .

Earnings released on 31 Mar 2022

EPS came in at -kr 0.62 , while revenue for the quarter reached kr 1.19M .

Dividend declared on 15 Mar 2022

A dividend of kr 0.29 per share was announced, adjusted to kr 0.29.

Earnings released on 31 Dec 2021

EPS came in at -kr 0.67 , while revenue for the quarter reached kr 1.19M .

Earnings released on 30 Sept 2021

EPS came in at -kr 0.57 , while revenue for the quarter reached kr 1.19M .

Earnings released on 30 Jun 2021

EPS came in at -kr 0.49 , while revenue for the quarter reached kr 2.31M .

Earnings released on 31 Mar 2021

EPS came in at -kr 0.64 , while revenue for the quarter reached kr 1.59M .

Earnings released on 31 Dec 2020

EPS came in at -kr 0.71 , while revenue for the quarter reached kr 1.57M .

Earnings released on 30 Sept 2020

EPS came in at -kr 0.57 , while revenue for the quarter reached kr 1.96M .

0JGL.L Stock Performance

Access detailed 0JGL.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.